These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4447785)

  • 21. Hormonal profiles after the menopause.
    Chakravarti S; Collins WP; Forecast JD; Newton JR; Oram DH; Studd JW
    Br Med J; 1976 Oct; 2(6039):784-7. PubMed ID: 974609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma oestradiol and progesterone in benign breast disease.
    Swain MC; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1973 Aug; 9(8):553-6. PubMed ID: 4788843
    [No Abstract]   [Full Text] [Related]  

  • 25. Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma.
    Theve NO; Carlström K; Gustafsson JA; Gustafsson S; Nordenskjöld B; Sköldefors H; Wrange O
    Eur J Cancer (1965); 1978 Dec; 14(12):1337-40. PubMed ID: 738338
    [No Abstract]   [Full Text] [Related]  

  • 26. Oestrogen metabolism in cultured human breast tumours.
    Willcox PA; Thomas GH
    Br J Cancer; 1972 Dec; 26(6):453-60. PubMed ID: 4345953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
    Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
    Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative oestradiol levels - relation to survival in breast cancer.
    Holmberg L; Nordén T; Lindgren A; Wide L; Degerman M; Adami HO
    Eur J Surg Oncol; 2001 Mar; 27(2):152-6. PubMed ID: 11289750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.
    Reed MJ; Cheng RW; Noel CT; Dudley HA; James VH
    Cancer Res; 1983 Aug; 43(8):3940-3. PubMed ID: 6683128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
    Sherman BM; West JH; Korenman SG
    J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast.
    Benedetto C; Zonca M; Tavella AM; Petitti E; Massobrio M; Nigam S; Slater TF
    Br J Cancer; 1985 Jan; 51(1):49-53. PubMed ID: 3881119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dehydroepiandrosterone sulfate, estradiol and non-protein-bound estradiol serum concentrations in postmenopausal women with and without breast disease.
    Dalski J; Schumann W; Görlich M
    Tumori; 1998; 84(6):720-1. PubMed ID: 10080685
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dyshormonal diseases of the breast].
    Ismaĭlov AKh
    Khirurgiia (Mosk); 1978 Nov; (11):115-8. PubMed ID: 723157
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolactin concentrations in patients with breast cancer.
    Franks S; Ralphs DN; Seagroatt V; Jacobs HS
    Br Med J; 1974 Nov; 4(5940):320-1. PubMed ID: 4434088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
    Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
    Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases.
    Langley MS; Hammond GL; Bardsley A; Sellwood RA; Anderson DC
    J Natl Cancer Inst; 1985 Nov; 75(5):823-9. PubMed ID: 3863985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
    Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
    Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Prolactin in benign and malignant breast disease.
    Cole EN; England PC; Sellwood RA; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of birth weight and adult body composition on 17beta-estradiol levels in young women.
    Finstad SE; Emaus A; Potischman N; Barrett E; Furberg AS; Ellison PT; Jasienska G; Thune I
    Cancer Causes Control; 2009 Mar; 20(2):233-42. PubMed ID: 18853264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.